PT - JOURNAL ARTICLE AU - Gialluisi, Alessandro AU - Di Castelnuovo, Augusto AU - Costanzo, Simona AU - Bonaccio, Marialaura AU - Persichillo, Mariarosaria AU - Magnacca, Sara AU - De Curtis, Amalia AU - Cerletti, Chiara AU - Donati, Maria Benedetta AU - de Gaetano, Giovanni AU - Capobianco, Enrico AU - Iacoviello, Licia AU - , TI - Exploring domains, clinical implications and environmental associations of a deep learning marker of biological ageing AID - 10.1101/2021.01.22.21250338 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.22.21250338 4099 - http://medrxiv.org/content/early/2021/01/26/2021.01.22.21250338.short 4100 - http://medrxiv.org/content/early/2021/01/26/2021.01.22.21250338.full AB - Deep Neural Networks (DNN) have been recently developed for the estimation of Biological Age (BA), the hypothetical underlying age of an organism, which can differ from its chronological age (CA). Although promising, these population-specific algorithms warrant further characterization and validation, since their biological, clinical and environmental correlates remain largely unexplored.Here, an accurate DNN was trained to compute BA based on 36 circulating biomarkers in an Italian population (N=23,858; age≥35 years; 51.7% women). This estimate was heavily influenced by markers of metabolic, heart, kidney and liver function. The resulting Δage (BA-CA) significantly predicted mortality and hospitalization risk for all and specific causes. Slowed biological aging (Δage<0) was associated with higher physical and mental wellbeing, healthy lifestyles (e.g. adherence to Mediterranean diet) and higher socioeconomic status (educational attainment, household income and occupational status), while accelerated aging (Δage>0) was associated with smoking and obesity. Together, lifestyles and socioeconomic variables explained □48% of the total variance in Δage, potentially suggesting the existence of a genetic basis.These findings validate blood-based biological aging as a marker of public health in adult Italians and provide a robust body of knowledge on its biological architecture, clinical implications and potential environmental influences.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank the BiomarCaRE Investigators for testing some of the markers used in this study and Dr Nina Tirozzi for the refinement of artwork. This study was partially supported by the Italian Ministry of Economic Development (PLATONE project, bando "Agenda Digitale" PON I&C 2014-2020; Prog. n. F/080032/01-03/X35) and by the Italian Ministry of Health (grant RF-2018-12367074 to GdG and SC). AG, MB and SC were supported by Fondazione Umberto Veronesi. The Moli-sani Study Investigators thank the Associazione Cuore Sano Onlus (Campobasso, Italy) for its cultural and financial support. The enrolment phase of the Moli-sani Study was supported by research grants from Pfizer Foundation (Rome, Italy), the Italian Ministry of University and Research (MIUR, Rome, Italy) Programma Triennale di Ricerca, Decreto no. 1588 and Instrumentation Laboratory, Milan, Italy. Funders had no role in this study design, collection, analysis, and interpretation of data, nor in the writing and submission phase of the manuscript. All Authors were and are independent from funders and declare no conflicts of interest.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Moli-sani study was approved by the Ethical Committee of the Catholic University of Rome.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and codes supporting the findings of this study are available from the corresponding author (alessandro.gialluisi@gmail.com) and/or from the senior author of the manuscript (licia.iacoviello@moli-sani.org) upon request.